obesity-995x60.png
FEATURED ARTICLES
Examining The Potential Of P-tau217 To Provide Earlier Diagnosis Of Alzheimer's
P-tau217 blood tests could accelerate Alzheimer’s diagnosis. Lilly’s Nino Sireci, MD, MSc, explains the research, evidence thus far, potential clinical use, and next steps.
-
![International Womans Day-GettyImages-2259815511]( "Autoimmune Drugs For Women: What To Bring To The Clinic")
Autoimmune Drugs For Women: What To Bring To The ClinicAutoimmune disease is one of the most sex-skewed categories in medicine. Sex, reproductive status, and hormonal state should not be treated as background noise.
-
![Robert Goldman]( "Small Biotech Can Outsource The Work, But Not The Thinking")
Small Biotech Can Outsource The Work, But Not The ThinkingRobert Goldman explains why small biotechs can outsource clinical trial work—but never accountability. His advice on CRO oversight and responsible AI adoption shows how lean sponsors can gain efficiency without surrendering the judgment needed to spot risks and protect their programs.
-
![site contract-gettyimages-2267854910]( "The Real Cost Of Sites Working Without An Enforceable Agreement: Why Your Site's Quality Of Earnings Is Suspect")
The Real Cost Of Sites Working Without An Enforceable Agreement: Why Your Site's Quality Of Earnings Is SuspectStarting site work before an enforceable agreement may look like flexibility, but it can drain leverage, create unrecoverable costs, and raise financial reporting and GCP concerns.
SERVICES AND PRODUCTS
Ypsomed accelerates clinical progress by reducing barriers across clinical development, enabling earlier study readiness, greater visibility and more informed decisions.
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.
YpsoDose supports a broad range of formulation and injection requirements. Its intuitive design ensures reliable, comfortable injections across conditions and environments.
Mobile ophthalmic clinical research and clinical trial on-site support services designed to address challenges across all trial phases and ensure reliable protection of ocular endpoints.